Cargando…

Molecular Characterization of Gallbladder Cancer using Somatic Mutation Profiling

Gallbladder cancer is relatively uncommon with high incidence in certain geographic locations, including Latin America, East and South Asia and Eastern Europe. Molecular characterization of this disease has been limited and targeted therapy options for advanced disease remain an open area of investi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Javle, Milind, Rashid, Asif, Churi, Chaitanya, Kar, Siddhartha, Zuo, Mingxin, Eterovic, Agda Karina, Nogueras-Gonzalez, Graciela M., Ali, Siraj, Janku, Filip, Shroff, Rachna, Aloia, Thomas A, Vauthey, Jean-Nicholas, Curley, Steven, Mills, Gordon, Roa, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428571/ https://www.ncbi.nlm.nih.gov/pubmed/24508317 http://dx.doi.org/10.1016/j.humpath.2013.11.001

Ejemplares similares

Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications
por: Churi, Chaitanya R., et al.
Publicado: (2014)

RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer
por: Zuo, Mingxin, et al.
Publicado: (2016)

HER2/neu-directed therapy for biliary tract cancer
por: Javle, Milind, et al.
Publicado: (2015)

Inactivation of tumor suppressor gene pten in early and advanced gallbladder cancer
por: Roa, Iván, et al.
Publicado: (2015)

Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer
por: Zuo, M, et al.
Publicado: (2015)

LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy
por: Zuo, Mingxin, et al.
Publicado: (2015)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer
por: Javle, Milind, et al.
Publicado: (2014)

Phase II Study of Panitumumab in RAS Wild‐Type Metastatic Adenocarcinoma of Small Bowel or Ampulla of Vater
por: Gulhati, Pat, et al.
Publicado: (2017)

Targeted Therapy of Advanced Gallbladder Cancer and Cholangiocarcinoma with Aggressive Biology: Eliciting Early Response Signals from Phase 1 trials
por: Subbiah, Ishwaria M., et al.
Publicado: (2013)

Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma
por: Abdel-Wahab, Reham, et al.
Publicado: (2018)

A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
por: Arango, Natalia Paez, et al.
Publicado: (2017)

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies
por: Javle, Milind M, et al.
Publicado: (2010)

Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
por: Arango, Natalia Paez, et al.
Publicado: (2019)

KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary
por: Vauthey, J-N, et al.
Publicado: (2012)

Epidemiology of gallbladder cancer
por: Rawla, Prashanth, et al.
Publicado: (2019)

Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer
por: Abdel-Wahab, Reham, et al.
Publicado: (2020)

ASO Author Reflections: Gallbladder Cancer Research, “One for All and All for One” Strategy to Improve Research
por: Vega, Eduardo A., et al.
Publicado: (2021)

Updates in Gastrointestinal Oncology – insights from the 2008 44(th )annual meeting of the American Society of Clinical Oncology
por: Javle, Milind, et al.
Publicado: (2009)

Recent advances in gastrointestinal oncology - updates and insights from the 2009 annual meeting of the American Society of Clinical Oncology
por: Javle, Milind, et al.
Publicado: (2010)

Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma
por: Chun, Yun Shin, et al.
Publicado: (2017)

ClinSeK: a targeted variant characterization framework for clinical sequencing
por: Zhou, Wanding, et al.
Publicado: (2015)

Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?
por: Fogelman, David R., et al.
Publicado: (2014)

Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma
por: Rogers, Jane E., et al.
Publicado: (2020)

Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization
por: Tran Cao, Hop, et al.
Publicado: (2020)

Environmental and Lifestyle Risk Factors in the Carcinogenesis of Gallbladder Cancer
por: Pérez-Moreno, Pablo, et al.
Publicado: (2022)

Role of lncRNAs in the Development of an Aggressive Phenotype in Gallbladder Cancer
por: Pérez-Moreno, Pablo, et al.
Publicado: (2021)

DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer
por: Letelier, Pablo, et al.
Publicado: (2012)

Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors
por: Javle, Milind, et al.
Publicado: (2023)

Laparoscopic Cholecystectomy for Gallbladder Calculosis in Fibromyalgia Patients: Impact on Musculoskeletal Pain, Somatic Hyperalgesia and Central Sensitization
por: Costantini, Raffaele, et al.
Publicado: (2016)

A Web-Based Tool for Patient Triage in Emergency Department Settings: Validation Using the Emergency Severity Index
por: Elias, Pierre, et al.
Publicado: (2015)

Choledochal Cyst Mimicking Gallbladder with Stones in a Six-Year-Old with Right-sided Abdominal Pain
por: Subramony, Rachna, et al.
Publicado: (2015)

The neutrophil-to-lymphocyte ratio: a narrative review
por: Faria, Sara Socorro, et al.
Publicado: (2016)

Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer
por: Liu, Zhiwei, et al.
Publicado: (2018)

Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2
por: Zhang, Lingmin, et al.
Publicado: (2012)

Context-dependent selection as the keystone in the somatic evolution of cancer
por: Vibishan, B., et al.
Publicado: (2020)

Metadata Correction: A Web-Based Tool for Patient Triage in Emergency Department Settings: Validation Using the Emergency Severity Index
por: Elias, Pierre, et al.
Publicado: (2015)

FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice
por: Kommalapati, Anuhya, et al.
Publicado: (2021)

Gallbladder Volume Indicated for Gallbladder Dysmotility
por: Liu, Linlin, et al.
Publicado: (2017)

Aspirin and Statin Use and the Risk of Gallbladder Cancer
por: Prasai, Kritika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tsefpq4ufsrcr6jq46jmdalegv